Nalaganje...
Therapeutic Antibodies for Myeloid Neoplasms—Current Developments and Future Directions
Therapeutic monoclonal antibodies (mAbs) such as antibody–drug conjugates, ligand–receptor antagonists, immune checkpoint inhibitors and bispecific T cell engagers have shown impressive efficacy in the treatment of multiple human cancers. Numerous therapeutic mAbs that have been developed for myeloi...
Shranjeno v:
| izdano v: | Front Oncol |
|---|---|
| Glavni avtor: | |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Frontiers Media S.A.
2018
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5968093/ https://ncbi.nlm.nih.gov/pubmed/29868474 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2018.00152 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|